Hemorrhagic complications of anticoagulant treatment

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 511S-523S

  Levine, Mark N ^a   Raskob, Gary ^a   Landefeld, Seth ^a   Kearon, Clive ^a  

^a Ontario Cancer Foundation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DICOUMAROL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; WARFARIN;

ANTICOAGULATION; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

EID: 0031760827     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.511S     Document Type: Conference Paper

References (3)

1. Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1986; 89(suppl): 15-25
2. Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1989; 95(suppl): 26-35
3. Levine MN, Hirsh J, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 1992; 102(suppl):352-363